A 41-year-old police officer presented for evaluation of a 3-to 4-month history of hoarseness, cough, and increased mucus production that had begun shortly after he began taking inhaled fluticasone/salmeterol (250/50 μg, delivered by dry powder inhaler) and pirbuterol (as needed) for asthma. In addition to his asthma, he had a long history of allergies, and he was also taking levocetirizine, nasal azelastine, montelukast, and nasal ipratropium. He had been previously evaluated by a local otolaryngologist who had diagnosed laryngopharyngeal reflux and prescribed esomeprazole at 40 mg daily and nizatidine at bedtime. The patient estimated that this regimen decreased his coughing by 85%.
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Strobovideolaryngoscopy revealed bulky, irregular vocal fold masses bilaterally, which were thought to possibly represent papillomas or an infiltrative process (figure 1, A). This investigation also revealed reflux laryngitis, and it identified muscle tension dysphonia and mild right superior laryngeal nerve paresis.
The patient's esomeprazole was increased to 40 mg twice daily, and he was to told to continue taking nizatidine at bedtime. A 1-week course of fluconazole was prescribed, along with prednisone at 60 mg for 7 days with a taper. He was instructed to maintain strict voice rest for 1 week. It was also recommended that he discuss with his allergist the possibility of discontinuing the fluticasone/salmeterol dry powder inhaler. He was advised that a surgical biopsy might be necessary if the lesions did not resolve, and computed tomography of the larynx was ordered.
Two weeks later, the patient was reevaluated. He reported no improvement in his voice despite compliance with all prescribed medications and voice rest. Strobovideolaryngoscopy again showed the presence of bilateral fibrotic, irregular, inflammatory vocal fold masses that were slightly smaller than those seen during his initial examination. Milky secretions seen in the mucosal folds of the piriform sinuses were consistent with thrush. The patient was still coughing. He was again placed on strict voice rest, and he was prescribed a 2-week course of nystatin for the thrush and tramadol, benzonatate, and guaifenesin 600 mg twice daily for the cough. He was instructed to continue the fluconazole for another 2 weeks. His esomeprazole dosage was increased to 80 mg before breakfast, 40 mg before lunch, and 40 mg before dinner. Additionally, the nizatidine was discontinued, and ranitidine 300 mg at bedtime was added to help control the reflux component of his disease. After consultation with the allergist, the fluticasone/salmeterol and pirbuterol were discontinued and replaced with low-dose prednisone to help control the asthma.
One week later, the patient returned. He said he had been silent during the preceding week, and he reported that his cough had resolved completely. Stroboscopic examination revealed that the size of his vocal fold masses had decreased bilaterally.
Four weeks later, the patient reported only an occasional cough after administering nasal spray. His medications included nasal azelastine, nasal ipratropium, esomeprazole three times daily, ranitidine at night, tramadol, montelukast, levocetirizine, and guaifenesin twice daily. Strobovideolaryngoscopy revealed nearcomplete resolution of the vocal fold lesions ( figure 1,  B) .
The patient was seen for follow-up approximately 1 month later, which was almost 3 months after his initial presentation. Strobovideolaryngoscopy revealed that the status of both vocal folds was within normal limits (figure 2). He remained off all asthma inhalers and prednisone, and he was advised to discuss with his allergist a switch from steroid inhalers to oral medications and possibly nebulizer therapy. He was allowed to return to work without restrictions.
Asthma inhalers are increasingly being recognized as contributors to fungal infections in the larynx. 1 The laryngoscopic appearance of fungal infections can vary; in severe cases, these infections can cause an intense inflammatory reaction that mimics a neoplastic process. Therefore, the use of steroid asthma inhalers is important in the history. Similarly, one of the most crucial parts of the treatment of fungal infections is stopping the use of the inhalers and controlling other aggravating factors, such as cough and reflux disease. 
